The recent advances in molecular imaging techniques, using cancer-targeting nanoparticle probes, provide noninvasive tracking information on cancer cells in living subjects.
Kang, H +23 more
core +1 more source
AS1411 is a 26-base DNA aptamer which is shortly due to enter a phase IIb clinical trial in acute myeloid leukaemia (AML). In an initial phase II trial in AML, combination of AS1411 with cytarabine produced an increased response rate compared to ...
David Jones +4 more
core +1 more source
In the study, the novel indium(III) phthalocyanines containing 4-mercaptopyridine groups as substituents on the peripheral (Pc3) or non-peripheral (Pc8) tetra-and peripheral octa (Pc13) positions were synthesized.
Akkus, Nurefsan +8 more
core +1 more source
Aptamer-functionalized exosomes co-delivering miR-934 inhibitor and gemcitabine for targeted pancreatic cancer therapy. [PDF]
Bi J +9 more
europepmc +1 more source
[Ultrasound-synergized targeted nanoparticles suppress proliferation, migration and invasion of hypoxic lung cancer cells <i>in vitro</i>]. [PDF]
Dong J, Guo J, Li D, DU Y.
europepmc +1 more source
Molecular Engineering of Aptamers for Glioblastoma Therapy: From Simple Antagonists to AI-Driven Approaches, a Narrative Review. [PDF]
Di Leandro L +8 more
europepmc +1 more source
Cytotoxic T lymphocyte-inspired nanotherapeutics chaperoning granzyme B for tumor immune remodeling. [PDF]
Chen Y +9 more
europepmc +1 more source
Proteomic Characterization of AS1411 Reveals ATP6AP1 as a Mediator of Triple-Negative Breast Cancer Progression. [PDF]
Bae HS +6 more
europepmc +1 more source
High-Sensitivity Magnetic Particle Spectroscopy Platform for Precise, Specific, and Rapid Detection of Infectious Disease and Cancer-Related Biomarkers. [PDF]
Ashfaq Ahmad H +6 more
europepmc +1 more source
Synthetic aptamer mechanoreceptors enable cell-specific force sensing and temporal control via DNA circuits. [PDF]
Xu T, Sethi S, Drees C, Walther A.
europepmc +1 more source

